This is a great share4 Nov 2019 09:24
to be involved with.
IPO was at 2.50
It went to 8.00 plus on Traumakine alone.
We now have Clevegen as well which looks to be doing very well on early trials.
Partners very interested.
Looking into the American market.
All that happened on Friday was MMs cashing in on PI sellers
Come on Farn